Search clinical trials for: nasopharyngeal carcinoma,donafeinib

Total 1113 results

Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Streptococcus Pneumoniae Serotype Carriage Rate for Nasopharyngeal Carriage in Filipino Children

Pneumonia, Bacterial
Theradex

Unknown

Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer

Head and Neck Cancer

United States
Assistance Publique - Hôpitaux de Paris
Association des Réseaux Bronchiolite

Completed

Evaluation of Chest Physiotherapy for Acute Bronchiolitis in Toddlers (BRONKINOU) (BRONKINOU)

Viral Bronchiolitis

France
National Institutes of Health Clinical Center (CC)

Completed

Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer

Nasopharyngeal Neoplasms

United States
Javelin Pharmaceuticals

Completed

Absolute Bioavailability and Nasopharyngeal Absorption of Intranasal Ketamine

Healthy

United States
University Hospital, Ghent

Completed

Double-Blind Randomized Placebo-Controlled Trial on Clinical and Biological Effects of Oral Corticosteroids or Doxycyclin in Patients With Nasal Polyposis

Nasal Polyposis

Belgium
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Streptococcus Pneumoniae Nasopharyngeal Carriage Rate in Children Receiving Prevnar®

Pneumococcal Infections
AstraZeneca

Completed

Effect of Iressa With/Without Concurrent Chemoradiotherapy on Tumor Gene Expression Profiles in Patients With Advanced Non-Nasopharyngeal Head and Neck Carcinoma

Head and Neck Cancer

Hong Kong, Singapore
Radboud University Medical Center
Dutch Cancer Society

Unknown

Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous Polyposis

Adenomatous Polyposis Coli

Netherlands
National Taiwan University Hospital

Unknown

Treatment Result of KTP Laser Nasopharyngectomy in Recurrent NPC Patients

Nasopharyngeal Carcinoma | Recurrent

Taiwan
National Taiwan University Hospital

Unknown

Whole-Body 18F-FDG PET in Induction Chemotherapeutic Response for Advanced NPC Patients

Nasopharyngeal Cancer

Taiwan
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

PHASE III TRIAL COMPARING, NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY VERSUS THE SAME NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY ASSOCIATED WITH DAILY HYDROXYUREA IN THE TREATMENT OF LOCALLY ADVANCED UNDIFFERENTIATED CARCINOMA NASOPHARYNGEAL TYPE.

LOCALLY ADVANCED UNDIFFERENTIATED CARCINOMA NASOPHARYNGEAL TYPE UCNT

France
National Taiwan University Hospital
National Health Research Institutes, Taiwan

Unknown

Molecular Mechanism of Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Taiwan

3

Subscribe